COMP and colorectal cancer: Thus, inhibiting COMP is a promising target for cancer treatments, particularly as COMP has been found to be highly expressed in and causes increased incidence of metastasis and proliferation of multiple cancer types including, breast, prostate, and colorectal cancers [6,12,14,15,16,17,18,19].